OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Understanding Angiotensin II Type 1 Receptor Signaling in Vascular Pathophysiology
Satoru Eguchi, Tatsuo Kawai, Rosario Scalia, et al.
Hypertension (2018) Vol. 71, Iss. 5, pp. 804-810
Open Access | Times Cited: 175

Showing 1-25 of 175 citing articles:

Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty
Luigi Ferrucci, Elisa Fabbri
Nature Reviews Cardiology (2018) Vol. 15, Iss. 9, pp. 505-522
Open Access | Times Cited: 2477

The cytokine storm and COVID‐19
Biying Hu, Shaoying Huang, Lianghong Yin
Journal of Medical Virology (2020) Vol. 93, Iss. 1, pp. 250-256
Open Access | Times Cited: 1467

IL-6 in inflammation, autoimmunity and cancer
Toshio Hirano
International Immunology (2020) Vol. 33, Iss. 3, pp. 127-148
Open Access | Times Cited: 876

COVID-19: A New Virus, but a Familiar Receptor and Cytokine Release Syndrome
Toshio Hirano, Masaaki Murakami
Immunity (2020) Vol. 52, Iss. 5, pp. 731-733
Open Access | Times Cited: 762

How COVID-19 induces cytokine storm with high mortality
Shintaro Hojyo, M. Uchida, Kumiko Tanaka, et al.
Inflammation and Regeneration (2020) Vol. 40, Iss. 1
Open Access | Times Cited: 627

Immune response in COVID-19: addressing a pharmacological challenge by targeting pathways triggered by SARS-CoV-2
Michele Catanzaro, Francesca Fagiani, Marco Racchi, et al.
Signal Transduction and Targeted Therapy (2020) Vol. 5, Iss. 1
Open Access | Times Cited: 598

Endothelial activation and dysfunction in COVID-19: from basic mechanisms to potential therapeutic approaches
Yuefei Jin, Wangquan Ji, Haiyan Yang, et al.
Signal Transduction and Targeted Therapy (2020) Vol. 5, Iss. 1
Open Access | Times Cited: 366

Neutrophils and Neutrophil Extracellular Traps Drive Necroinflammation in COVID-19
Bhawna Tomar, Hans‐Joachim Anders, Jyaysi Desai, et al.
Cells (2020) Vol. 9, Iss. 6, pp. 1383-1383
Open Access | Times Cited: 257

ACE2/ADAM17/TMPRSS2 Interplay May Be the Main Risk Factor for COVID-19
Donato Zipeto, Julys da Fonseca Palmeira, Gustavo Adolfo Argañaraz, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 243

Cytokine storm syndrome in coronavirus disease 2019: A narrative review
Yue-Ming Gao, Gang Xu, Bin Wang, et al.
Journal of Internal Medicine (2020) Vol. 289, Iss. 2, pp. 147-161
Open Access | Times Cited: 201

Inflammation, Frailty and Cardiovascular Disease
Pınar Soysal, Ferhat Arık, Lee Smith, et al.
Advances in experimental medicine and biology (2020), pp. 55-64
Closed Access | Times Cited: 197

Curcumin as a Potential Treatment for COVID-19
Bruna Rattis, Simone G. Ramos, Mara Rúbia Nunes Celes
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 127

COVID-19, Myocarditis and Pericarditis
DeLisa Fairweather, Danielle J. Beetler, Damian N. Di Florio, et al.
Circulation Research (2023) Vol. 132, Iss. 10, pp. 1302-1319
Open Access | Times Cited: 119

Cytokine storm in COVID-19: from viral infection to immune responses, diagnosis and therapy
Yi-Zhou Jiang, Limor Rubin, Tangming Peng, et al.
International Journal of Biological Sciences (2021) Vol. 18, Iss. 2, pp. 459-472
Open Access | Times Cited: 113

Molecular pathways involved in COVID-19 and potential pathway-based therapeutic targets
Masoumeh Farahani, Zahra Niknam, Leila Mohammadi Amirabad, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 145, pp. 112420-112420
Open Access | Times Cited: 102

ACE2 in the Era of SARS-CoV-2: Controversies and Novel Perspectives
Federica Saponaro, Grazia Rutigliano, Simona Sestito, et al.
Frontiers in Molecular Biosciences (2020) Vol. 7
Open Access | Times Cited: 98

Vasculopathy and Coagulopathy Associated with SARS-CoV-2 Infection
Nazzarena Labò, Hidetaka Ohnuki, Giovanna Tosato
Cells (2020) Vol. 9, Iss. 7, pp. 1583-1583
Open Access | Times Cited: 86

COVID-19 Associated Ischemic Stroke and Hemorrhagic Stroke: Incidence, Potential Pathological Mechanism, and Management
Zilan Wang, Yanbo Yang, Xiaolong Liang, et al.
Frontiers in Neurology (2020) Vol. 11
Open Access | Times Cited: 86

Neutrophil activation and neutrophil extracellular traps (NETs) in COVID‐19 ARDS and immunothrombosis
Maria Candida Cesta, Mara Zippoli, Carolina Marsiglia, et al.
European Journal of Immunology (2022) Vol. 53, Iss. 1
Open Access | Times Cited: 68

SARS-CoV-2/ACE2 Interaction Suppresses IRAK-M Expression and Promotes Pro-Inflammatory Cytokine Production in Macrophages
Ioanna Pantazi, Ahmed A. Al‐Qahtani, Fatimah S. Alhamlan, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 57

Covid‐19 and Liver Injury: Role of Inflammatory Endotheliopathy, Platelet Dysfunction, and Thrombosis
Matthew J. McConnell, Reiichiro Kondo, Nao Kawaguchi, et al.
Hepatology Communications (2021) Vol. 6, Iss. 2, pp. 255-269
Open Access | Times Cited: 56

Tocilizumab and COVID-19: Timing of Administration and Efficacy
Emna Abidi, Wasim S. El Nekidy, Eman Alefishat, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 44

Multisystem Inflammatory Syndrome and Autoimmune Diseases Following COVID-19: Molecular Mechanisms and Therapeutic Opportunities
Parastoo Hosseini, Mohammad Sadegh Fallahi, Gisou Erabi, et al.
Frontiers in Molecular Biosciences (2022) Vol. 9
Open Access | Times Cited: 39

Renin-Angiotensin System: Updated Understanding and Role in Physiological and Pathophysiological States
Ashok Kumar Kanugula, Jasleen Kaur, Jaskaran Batra, et al.
Cureus (2023)
Open Access | Times Cited: 23

Page 1 - Next Page

Scroll to top